Prognostic Significance of CD27 and CD56 on Newly Diagnosed MM Patients Treated with Bortezomib / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 827-831, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-880154
ABSTRACT
OBJECTIVE@#To investigate the significance of CD27 and CD56 in the prognosis of multiple myeloma (MM) patients, and to establish a simple and convenient prognostic risk score.@*METHODS@#One hundred and eleven newly diagnosed MM patients treated by bortezomib in Shengjing hospital from January 1, 2013 to January 1, 2019 were selected, and the relationship between clinical characteristics and survival time of patients was analyzed.@*RESULTS@#The overall survival (OS) of patients in CD27@*CONCLUSION@#Among patients with MM treated by bortezomib, CD27
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Estudios Retrospectivos
/
Trasplante de Células Madre Hematopoyéticas
/
Antígeno CD56
/
Bortezomib
/
Mieloma Múltiple
Tipo de estudio:
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS